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STUDIES ON THE PERCUTANEOUS ABSORPTION OF PARATHION
AND PARAOXON
VI. IN Vivo DECOMPOSITION OF PARAOXON DURING THE EPIDERMAL
PASSAGE *
TORSTEN FREDRIKSSON, M.D.
In five earlier papers of this series various as-
pects of the percutaneous absorption of the well-
known insecticide parathion (E 605, or diethyl
4-nitrophenyl thionophosphate) and its more
toxic oxygen analogue paraoxon (E 600, or
diethyl 4-nitrophenyl phosphate) were discussed.
These studies covered such topics as the in vitro
metabolism and enzymic degradation within the
skin (8) the distribution of 32P-labelled parathion
within the skin (2); the rate of absorption of
parathion as investigated with the aid of labelled
material and disappearance technic (3); decon-
tamination of human skin from parathion (4);
and also the rate of absorption of paraoxon (5).
The method used in the last mentioned case was
a dose-response technic, i.e. the rate of inhibi-
tion of plasma cholincsterase activity was deter-
mined following percutaneous absorption and
continuous intravenous infusion in two separate
groups of cats. The intravenous infusion was ad-
justed so that the rate of enzyme inhibition in
plasma was approximately the same as following
topical application. Since the rate of infusion and
the area of absorption were known the rate of
percutaneous absorption could easily be calcu-
lated.
This dose-response technic, however, only re-
veals the absorption of active inhibitor into the
blood-stream and does not account for any deg-
radation or other metabolism which may occur
within the skin during the passage from the
topical deposit to the capillary net. In the case of
paraoxou such decomposition is likely to occur
in vivo, since it has been shown (8) that the skin
of certain species—among them the cat—contains
enzymes capable of hydrolyzing this compound.
These enzymes belong to the group of phos-
phorylphosphatases and detoxify the inhibitor
so that it loses its potent anticholinesterase
activity.
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In contrast, the above mentioned disappear-
ance technic, where the decrease in radioactivity
of a topical deposit of labelled material is used as
a measure of the rate of absorption, shows the
total absorption, thus both of active inhibitor
and labelled decomposition products. If any
degradation occurs, the disappearance technic
will give higher values of the rate of absorption
than the dose-response method, and the difference
between the two rates will give a measare of the
in vivo decomposition of the inhibitor during its
cpidermal passage.
In view of this, a logical continuation of the
earlier work was to determine the rate of absorp-
tion of paraoxon also with the aid of the disap-
pearance technic, using the cat as experimental
animal. Parathion is of less interest in this con-
nection, since in vitro studies have not shown any
significant metabolism to occur in dermal tissues
(8).
METHODS
All methods and compounds used in the present
paper have been described previously in detail
(1, 2, 3, 5). Twelve cats weighing between 2.8 and
3.0 kg were used. The animals were anesthetized
with sodium pentobarbital (30 mg per kg body
weight), administered intraperitoneally. On a
clipped area on the lateral aspect of the thigh 50
/21 of undiluted 2P-labelled paraoxon (E 600, or
diethyl 4-nitrophenyl phosphate) with an initial
specific activity of 0.8 mC per mM was evenly
distributed over an area of 4.1 em2. Disappearance
measurements, demonstration of radioactivity in
blood, and determination of cholinesterasc
activity was done as described earlier (1). The
disappearance constant 4 was also calculated as
previously (1), and the same statistical methods
were used.
RESULTS AND DISCUSSION
The disappearance measurements, which are
illustrated by Figs. I—Ill and summarized in
Table I, gave uniform results in all the twelve
animals. Systemic cholinergic signs, such as sali-
vation, miosis and faseieulations were occasion-
Paraoxon
Parathion*
Sarin (iso-propoxy-methyl-
phosphoryl fiuoride)t
1-methyl-butoxy-methyl-phos-
phoryl-fluoridet
1-methyl-hexoxy-methyl-
phosphoryl fiuoride
Tri-n-butyl-phosphatel:
* From Fredriksson (3)
f From Fredriksson (1)
From Fredriksson (6)
ally seen. Respiration and blood pressure were
never abnormal during the experiments, which
continued for at least three hours. Fasciculations
in the muscles underlying the area of absorption
was the only local symptom noted, and this sign
occurred in all the animals about one hour from
application.
The disappearance curves, as illustrated by
Fig. I, had essentially the same shape as those
obtained with other organophosphorus com-
pounds labelled with a /-ray emitter (1, 3, 6).
The various phases of such curves have earlier
been discussed in detail (6). The constant phase
of the curves, which denotes the systemic absorp-
tion of the compound in question, was used to
calculate the disappearance constant k. In this
case it was found to have a value of 11 x 1O
with a standard error of X 1O—. As follows
from Table I this is a rather low value compared
with e.g. Sarin, and the mean rate of absorption,
as calculated from the disappearance constant, is
comparable to that of parathion. This can be ex-
pected, since both compounds have essentially
the same physico-chemical properties (9); the
only chemical difference being a substitution of a
sulfur atom with oxygen.
The radioactivity in blood was only slightly
higher than the background until the end of the
experiments, as in the case of parathion (3), but
there was a definite trend towards increasing
activity. In Fig. II the radioactivity in blood has
been expressed in g paraoxon per ml of blood, in
FIG. 1. Representative disappearance curve
following topical application of 50 ol 2P-labelled
paraoxon. Time is in minutes from application.
Cat, 3.0 kg, sodiumpentobarbital. Area of ab-
sorption 4.1 cm2. k 13 X 10.
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FIG. 2. Radioactivity in blood transformed
into ig of paraoxon per ml following topical
application of 50 il 32Plabelled paraoxon on 4.1
cm2. Number of animals: 12. Time in minutes
from beginning of application. Vertical lines
denote one standard deviation.
spite of the fact that it is derived from both un-
changed paraoxon and its 32P-containing metab-
olites. This curve, however, illustrates that
there is a tendency towards a constant level of
radioactive material in blood; a state of equilib-
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TABLE I
Disappearance constant and mean rate of absorption of paraoxon following topical application
of 50 p.l 32P-labelled material on 4.1 cm2 in the cat. For comparison corresponding
values for five other organophosphorus compounds are given
Compound Species DisappearanceConstant k min1
Mean Rate of Absorption
g min1 cm2 mplM min' cm2
cat
cat
cat
cat
cat
rabbit
11 X 10
9 X 10
10 X 10—U
18 X 10—U
8 X 10
4 X 10°
1.7
1.4
18
31
13
2.4
6
5
129
190
66
9
35
30
25
20
Ic
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Fin. 3. Inhibition of plasma eholinesterase activity in twelve cats following topical application of
50M1 parathion on 4.1 cm°. The enzyme activity is expressed as per cent of the initial activity, and timeis in minutes from application. Vertical lines represent one standard deviation. The mean, first order
velocity constant of inhibition is 0.010.
rium which earlier was observed in case of
Sarin and two of its analogues (1) and in case
of parathion (3). Other experiments (7) have also
shown that parathion, which compound produces
about the same level of radioactivity in blood
under comparable circumstances (3), is not ac-
cumulated in blood but in other tissues. Of course,
this lack of accumulation in blood does not indi-
cate a decrease of absorption with time but il-
lustrates the fact that blood is a mere transport
system.
The inhibition of plasma cholinesterase activity
following percutaneous absorption of paraoxon
is illustrated by Fig. III. The first order reaction
velocity constant of the inhibition of plasma
cholinesterase, calculated from the slope of the
curves according to the method given earlier (5),
has the value of 0.010 with a standard error of
0.001. This is in good agreement with earlier re-
sults obtained with non-labelled paraoxon (5).
Accordingly, radioactivity from a high energy
/3-ray emitter does not produce any injury to the
barrier towards absorption under these experi-
mental conditions and does not change the rate
of absorption of the labelled compound from the
topical deposit.
There is a great difference in the results ob-
tained with the two methods: the mean rate of
absorption obtained with the disappearance
technic is 1.7 pg min cm2, while the corre-
sponding value in case of the dose-response
method was about 0.2 pg min cm. Since the
effects on the plasma enzyme activity were iden-
tical, indicating that the same amount of active
inhibitor will reach the blood stream in both
cases, this means that a considerable amount of
the active inhibitor has been detoxified during
the passage from the topical deposit to the sub-
epidermal capillary net. Almost 90 per cent of the
active material is lost during this decomposition;
about the same figure as was obtained in the case
of Sarin (1). This high degree of decomposition is
also reasonable in view of the fact that it earlier
has been shown that cat skin is capable of split-
ting approximately 30 pg paraoxon per hour and
gram of tissue (1 g of cat skin equals 12—15 em2) at
25°C; a figure which is not optimal due to the
thickness of the skin slices and low temperature
(8). The passage through the epidermal layers
is also a fairly slow process; it was earlier shown
that the time required for paraoxon to diffuse
from the topical deposit to the blood stream is
approximately 12 minutes (5). In view of these
facts a 90 per cent enzymic decomposition during
the epidermal passage is a logical event.
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SUMMARY
The rate of percutaneous absorption of pa-
raoxon (E 600, or diethyl 4-nitrophenyl phos-
phate) has been determined in vim by following
the disappearance from a topical deposit of 32p
labelled material (50 pl applied on 4.1 cm2) in the
cat. The rate of absorption was found to be 6
mpM min cm2. The amount of radioactivity
in blood three hours after the application corre-
sponded to 0.05 pg paraoxon per ml, and there
was a tendency towards a constant level of radio-
active material in blood. The rate of inhibition of
plasma cholinesterase activity was the same as in
another series of experiments where the percu-
taneous absorption of nonlabelled paraoxon was
studied. This finding indicates that the radiation
from a high energy /3-ray emitter does not pro-
duce any injury to the barrier towards absorption.
Comparisons with a dose-response study of the
absorption, which only revealed the systemic
absorption of active inhibitor, indicated that
almost 90 per cent of the topically applied pa-
raoxon was detoxified before it was absorbed by
the capillary net. This in vivo decomposition
during the epidermal passage is reasonable, since
it has been shown previously that cat skin
contains enzymes capable of splitting paraoxon.
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